Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000784

Drug Information
NameMycophenolic acid
Trade NameCellCept; Myfortic
CompanyNorvatis Phamaceuticals Corporation
IndicationOrgan transplant rejection
[ICD9: 279.5, 996   ICD10: D89.8, T86]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10
(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)
InChIKeyHPNSFSBZBAHARI-UHFFFAOYSA-N
Canonical SMILESCC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC    
Therapeutic ClassAntineoplastic Agents
CAS NumberCAS 24280-93-1
FormulaC17H20O6
PubChem Compound IDCID 4272.
SuperDrug ATC IDL04AA06
SuperDrug CAS ID024280931;
TargetInosine-5'-monophosphate dehydrogenase 2Inhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050791 To Reference
Ref 2Clin Chem. 2009 May;55(5):986-93. Epub 2009 Mar 19.Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543